Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(SCHWARTZ S) > Common breast cance...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		28778naa a2203457 4500
001		oai:DiVA.org:hj-39678
003		SwePub
008		180601s2010 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:DiVA.org:umu-39274
009		oai:DiVA.org:uu-140191
009		oai:lup.lub.lu.se:805abb9d-d52c-4188-9ec1-0386d4b66928
009		oai:gup.ub.gu.se/135360
009		oai:prod.swepub.kib.ki.se:121669047
009		oai:DiVA.org:liu-63965
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-396782 URI
024	7	a https://doi.org/10.1158/0008-5472.CAN-10-19072 DOI
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-392742 URI
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1401912 URI
024	7	a https://lup.lub.lu.se/record/17517872 URI
024	7	a https://gup.ub.gu.se/publication/1353602 URI
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1216690472 URI
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-639652 URI
040		a (SwePub)hjd (SwePub)umud (SwePub)uud (SwePub)lud (SwePub)gud (SwePub)kid (SwePub)liu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Antoniou, A. C.u Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom,University Turin, Department Genet Biol and Biochem, Turin, Italy,IRCCS, Ist Oncol Veneto, Immunol and Mol Oncol Unit, Padua, Italy4 aut
245	1 0	a Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers :b Implications for risk prediction
264	1	b American Association for Cancer Research,c 2010
338		a print2 rdacarrier
500		a SWE-BRCA SWE-BRCA collaborators: Per Karlsson, Margareta Nordling, Annika Bergman, and Zakaria Einbeigi, Gothenburg, Sahlgrenska University Hospital; Sigrun Liedgren, Linkoping University Hospital; Niklas Loman, Ha kan Olsson, Ulf Kristoffersson, Helena Jernstr€om, Katja Harbst, and Karin Henriksson, Lund University Hospital; Brita Arver, Anna von Wachenfeldt, Annelie Liljegren, and Gisela Barbany-Bustinza, Stockholm, Karolinska University Hospital; Henrik Gronberg, Eva-Lena Stattin, and Monica Emanuelsson, Umea University Hos- € pital; Hans Ehrencrona, Richard Rosenquist Brandell, and Niklas Dahl, Uppsala University Hospital
500		a SWE-BRCA collaborators: Hans Ehrencrona, Richard Rosenquist Brandell and Niklas Dahl, Institutionen för genetik och patologi, Department of Genetics and Pathology, Uppsala University Hospital
520		a The known breast cancer susceptibility polymorphisms in FGFR2, TNRC9/TOX3, MAP3K1, LSP1, and 2q35 confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. We evaluated the associations of 3 additional single nucleotide polymorphisms (SNPs), rs4973768 in SLC4A7/NEK10, rs6504950 in STXBP4/COX11, and rs10941679 at 5p12, and reanalyzed the previous associations using additional carriers in a sample of 12,525 BRCA1 and 7,409 BRCA2 carriers. Additionally, we investigated potential interactions between SNPs and assessed the implications for risk prediction. The minor alleles of rs4973768 and rs10941679 were associated with increased breast cancer risk for BRCA2 carriers (per-allele HR = 1.10, 95% CI: 1.03-1.18, P = 0.006 and HR = 1.09, 95% CI: 1.01-1.19, P = 0.03, respectively). Neither SNP was associated with breast cancer risk for BRCA1 carriers, and rs6504950 was not associated with breast cancer for either BRCA1 or BRCA2 carriers. Of the 9 polymorphisms investigated, 7 were associated with breast cancer for BRCA2 carriers (FGFR2, TOX3, MAP3K1, LSP1, 2q35, SLC4A7, 5p12, P = 7 × 10-11 - 0.03), but only TOX3 and 2q35 were associated with the risk for BRCA1 carriers (P = 0.0049, 0.03, respectively). All risk-associated polymorphisms appear to interact multiplicatively on breast cancer risk for mutation carriers. Based on the joint genotype distribution of the 7 risk-associated SNPs in BRCA2 mutation carriers, the 5% of BRCA2 carriers at highest risk (i.e., between 95th and 100th percentiles) were predicted to have a probability between 80% and 96% of developing breast cancer by age 80, compared with 42% to 50% for the 5% of carriers at lowest risk. Our findings indicated that these risk differences might be sufficient to influence the clinical management of mutation carriers.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653		a BRCA1 protein
653		a BRCA2 protein
653		a adult
653		a aged
653		a article
653		a attributable risk
653		a breast cancer
653		a cancer risk
653		a cancer susceptibility
653		a clinical evaluation
653		a controlled study
653		a female
653		a follow up
653		a gene frequency
653		a gene mutation
653		a genotype
653		a heterozygote
653		a human
653		a major clinical study
653		a priority journal
653		a probability
653		a risk assessment
653		a single nucleotide polymorphism
653		a tumor suppressor gene
653		a Aged
653		a 80 and over
653		a Alleles
653		a Breast Neoplasms
653		a Genetic Predisposition to Disease
653		a Humans
653		a Middle Aged
653		a Mutation
653		a Polymorphism
653		a Single Nucleotide
653		a Receptors
653		a Progesterone
653		a Risk Factors
653		a Sodium-Bicarbonate Symporters
653		a Survival Analysis
653		a Vesicular Transport Proteins
653		a MEDICINE
653		a Adult
653		a Aged
653		a Aged, 80 and over
653		a Alleles
653		a BRCA1 Protein
653		a BRCA2 Protein
653		a Breast Neoplasms
653		a Female
653		a Genetic Predisposition to Disease
653		a Genotype
653		a Heterozygote
653		a Humans
653		a Middle Aged
653		a Mutation
653		a Polymorphism, Single Nucleotide
653		a Receptors, Progesterone
653		a Risk Assessment
653		a Risk Factors
653		a Sodium-Bicarbonate Symporters
653		a Survival Analysis
653		a Vesicular Transport Proteins
700	1	a Beesley, J.u Queensland Institute of Medical Research, Brisbane, Australia4 aut
700	1	a McGuffog, L.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England,Mayo Clin, Department Med Genet, Rochester, MN USA4 aut
700	1	a Sinilnikova, O. M.u Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France,IRCCS, Ist Oncol Veneto, Immunol and Mol Oncol Unit, Padua, Italy4 aut
700	1	a Healey, S.u Queensland Institute Med Research, Brisbane, Qld, Australia4 aut
700	1	a Neuhausen, S. L.u Beckman Research Institute City Hope, Department Populat Science, Duarte, CA USA,Aalborg Hospital, Department Clin Genet, Aalborg, Denmark,Roswell Pk Canc Institute, Department Canc Prevent and Control, Buffalo, NY 14263 USA4 aut
700	1	a Ding, Y. C.u Beckman Research Institute City Hope, Department Populat Science, Duarte, CA USA,Dana Farber Canc Institute, Boston, MA 02115 USA4 aut
700	1	a Rebbeck, T. R.u University Penn, Sch Med, Abramson Canc Centre, Philadelphia, PA 19104 USA4 aut
700	1	a Weitzel, J. N.u City Hope Natl Med Centre, Duarte, CA 91010 USA4 aut
700	1	a Lynch, H. T.u Creighton University, Omaha, NE 68178 USA,Pomeranian Med University, Int Hereditary Canc Centre, Department Genet and Pathol, Szczecin, Poland,Queensland Institute Med Research, Brisbane, Qld, Australia4 aut
700	1	a Isaacs, C.u Mayo Clin, Coll Med, Department Lab Med and Pathol, Rochester, MN USA4 aut
700	1	a Ganz, P. A.u University Calif Los Angeles, Jonsson Comprehens Canc Centre, Los Angeles, CA 90024 USA,Fdn IRCCS Ist Nazl Tumori INT, Unit Genet Susceptibil Canc, Department Expt Oncol and Mol Med, Milan, Italy4 aut
700	1	a Tomlinson, G.u University Texas Hlth Science Centre San Antonio, San Antonio, TX 78229 USA4 aut
700	1	a Olopade, O. I.u University Chicago, Med Centre, Chicago, IL 60637 USA4 aut
700	1	a Couch, F. J.u Mayo Clin, Department Lab Med and Pathol, Rochester, MN USA4 aut
700	1	a Wang, X.u Mayo Clin, Department Lab Med and Pathol, Rochester, MN USA4 aut
700	1	a Nordling, Margareta,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik,Institute of Biomedicine, Department of Medical and Clinical Genetics4 aut0 (Swepub:gu)xnmarx
700	1	a Pankratz, V. S.u Mayo Clin, Department Hlth Science Research, Rochester, MN USA4 aut
700	1	a Radice, P.u Fdn IRCCS Ist Nazl Tumori INT, Unit Genet Susceptibil Canc, Department Expt Oncol and Mol Med, Milan, Italy4 aut
700	1	a Manoukian, S.u Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Department Prevent and Predict Med, Milan, Italy4 aut
700	1	a Peissel, B.u Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Department Prevent and Predict Med, Milan, Italy4 aut
700	1	a Zaffaroni, D.u Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Department Prevent and Predict Med, Milan, Italy4 aut
700	1	a Stenmark-Askmalm, Marieu Östergötlands Läns Landsting,Linköpings universitet,Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine,Onkologi,Hälsouniversitetet,Klinisk patologi och klinisk genetik4 aut0 (Swepub:liu)marst93
700	1	a Viel, A.u IRCCS, CRO, Div Expt Oncol 1, Aviano, PN, Italy4 aut
700	1	a Allavena, A.u Karolinska Institutet,University Hospital, Department Pathol, Reykjavik, Iceland4 aut
700	1	a Dall'Olio, V.4 aut
700	1	a Peterlongo, P.4 aut
700	1	a Szabo, C. I.4 aut
700	1	a Zikan, M.u Charles University Prague, Fac Med 1, Department Biochem and Expt Oncol, Prague, Czech Republic4 aut
700	1	a Claes, K.u Ghent University Hospital, Centre Med Genet, B-9000 Ghent, Belgium4 aut
700	1	a Poppe, B.u Ghent University Hospital, Centre Med Genet, B-9000 Ghent, Belgium4 aut
700	1	a Foretova, L.u Masaryk Mem Canc Institute, Department Canc Epidemiol and Genet, Brno, Czech Republic4 aut
700	1	a Mai, P. L.u US Natl Canc Institute, Clin Genet Branch, Rockville, MD USA4 aut
700	1	a Greene, M. H.u US Natl Canc Institute, Clin Genet Branch, Rockville, MD USA4 aut
700	1	a Rennert, G.u Technion Israel Institute Technology, Carmel Med Centre, Haifa, Israel4 aut
700	1	a Lejbkowicz, F.u Technion Israel Institute Technology, Carmel Med Centre, Haifa, Israel4 aut
700	1	a Glendon, G.u OCGN, Toronto, ON, Canada4 aut
700	1	a Ozcelik, H.u Mt Sinai Hospital, Fred A Litwin Centre Canc Genet, Samuel Lunenfeld Research Institute, New York, NY 10029 USA,University Copenhagen, Rigshosp, Department Clin Biochem, DK-2100 Copenhagen, Denmark4 aut
700	1	a Andrulis, I. L.u OCGN, Toronto, ON, Canada4 aut
700	1	a Thomassen, M.u Odense University Hospital, Department Clin Genet, DK-5000 Odense, Denmark4 aut
700	1	a Gerdes, A. -Mu Rigshosp, Department Clin Genet, Odense, Denmark,Dana Farber Canc Institute, Boston, MA 02115 USA,Tech University Munich, Klinikum Rechts Isar, Department Obstet and Gynaecol, Div Tumor Genet, D-8000 Munich, Germany4 aut
700	1	a Sunde, L.4 aut
700	1	a Cruger, D.u Vejle Hospital, Department Clin Genet, Velje, Denmark4 aut
700	1	a Jensen, U. B.u Aarhus University Hospital, Department Clin Genet, DK-8000 Aarhus, Denmark4 aut
700	1	a Caligo, M.u University Pisa, Div Surg Mol and Ultrastruct Pathol, Department Oncol, Pisa, Italy4 aut
700	1	a Friedman, E.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel,University Chicago, Med Centre, Chicago, IL 60637 USA4 aut
700	1	a Kaufman, B.u Sheba Med Centre, Institute Oncol, Tel Hashomer, Israel4 aut
700	1	a Laitman, Y.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut
700	1	a Milgrom, R.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut
700	1	a Dubrovsky, M.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut
700	1	a Cohen, S.u Sheba Med Centre, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel4 aut
700	1	a Borg, A.u Lund University, Department Oncol, Lund, Sweden,Queensland Institute Med Research, Brisbane, Qld, Australia4 aut
700	1	a Jernström, Helenau Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Department Oncol, Lund, Sweden4 aut0 (Swepub:lu)onk-hje
700	1	a Lindblom, A.u Karolinska Institute, Department Mol Med and Surg, Stockholm, Sweden4 aut
700	1	a Rantala, J.u Karolinska Institutet,Karolinska Institute, Department Mol Med and Surg, Stockholm, Sweden4 aut
700	1	a Stenmark-Askmalm, M.4 aut
700	1	a Melin, Beatriceu Umeå universitet,Onkologi,Umea University, Department Radiat Science, Umea, Sweden4 aut0 (Swepub:umu)bema0010
700	1	a Nathanson, K.u University Penn, Philadelphia, PA 19104 USA4 aut
700	1	a Domchek, S.u University Penn, Philadelphia, PA 19104 USA4 aut
700	1	a Jakubowska, A.u Pomeranian Med University, Int Hereditary Canc Centre, Department Genet and Pathol, Szczecin, Poland,Leiden University, Med Centre, Department Clin Genet, Leiden, Netherlands4 aut
700	1	a Lubinski, J.u Pomeranian Med University, Int Hereditary Canc Centre, Department Genet and Pathol, Szczecin, Poland,University Melbourne, Melbourne, Vic, Australia4 aut
700	1	a Huzarski, T.4 aut
700	1	a Osorio, A.u Spanish Natl Canc Research Centre, Human Genet Grp, Human Canc Genet Programme, Madrid, Spain4 aut
700	1	a Lasa, A.u Hospital Santa Creu and Sant Pau, Genet Serv, Barcelona, Spain4 aut
700	1	a Durán, M.u University Valladolid, Institute Biol and Mol Genet, IBGM UVA, Valladolid, Spain4 aut
700	1	a Tejada, M. -Iu Cruces Hospital Barakaldo, Mol Genet Lab, Department Biochem, Bizkaia, Spain4 aut
700	1	a Godino, J.u University Lozano Blesa, Hospital Clin, Oncol Serv, Zaragoza, Spain4 aut
700	1	a Benitez, J.u Spanish Natl Canc Research Centre, Human Canc Genet Programme, Genotyping Unit, Madrid, Spain4 aut
700	1	a Hamann, U.u Deutsch Krebsforschungszentrum, Mol Genet Breast Canc, D-6900 Heidelberg, Germany4 aut
700	1	a Kriege, M.u Daniel Denhoed Canc Centre, Erasmus MC, Department Med Oncol, Family Canc Clin, Rotterdam, Netherlands4 aut
700	1	a Hoogerbrugge, N.u Radboud University Nijmegen, Nijmegen Med Centre, Hereditary Canc Clin, NL-6525 ED Nijmegen, Netherlands4 aut
700	1	a Van Der Luijt, R. B.u University Med Centre Utrecht, Department Med Genet, Utrecht, Netherlands4 aut
700	1	a Van Asperen, C. J.u Sheffield Childrens Hospital, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England4 aut
700	1	a Devilee, P.u Leiden University, Department Human Genet, Med Centre, Department Pathol, NL-2300 RA Leiden, Netherlands4 aut
700	1	a Meijers-Heijboer, E. J.u Vrije University Amsterdam Med Centre, Department Clin Genet, Amsterdam, Netherlands,Canc Prevent Institute Calif, Fremont, CA USA4 aut
700	1	a Blok, M. J.u University Med Centre, Department Genet and Cell Biol, Maastricht, Netherlands4 aut
700	1	a Aalfs, C. M.u University Amsterdam, Acad Med Centre, Department Clin Genet, NL-1105 AZ Amsterdam, Netherlands,University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut
700	1	a Hogervorst, F.u Netherlands Canc Institute, Family Canc Clin, Amsterdam, Netherlands4 aut
700	1	a Rookus, M.u Netherlands Canc Institute, Department Epidemiol, Amsterdam, Netherlands4 aut
700	1	a Cook, M.4 aut
700	1	a Oliver, C.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut
700	1	a Frost, D.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut
700	1	a Conroy, D.u University Cambridge, Department Oncol, Cambridge, England4 aut
700	1	a Evans, D. G.u Cent Manchester University Hospital NHS Fdn Trust, Manchester Acad Hlth Science Centre, Manchester, Lancs, England,University Utah, Department Dermatol, Salt Lake City, UT USA,Hannover Med Sch, Institute Cell and Mol Pathol, D-3000 Hannover, Germany4 aut
700	1	a Lalloo, F.u Cent Manchester University Hospital NHS Fdn Trust, Manchester Acad Hlth Science Centre, Manchester, Lancs, England4 aut
700	1	a Pichert, G.u Guys and St Thomas NHS Fdn Trust, London, England4 aut
700	1	a Davidson, R.u Ferguson Smith Centre Clin Genet, Glasgow, Lanark, Scotland4 aut
700	1	a Cole, T.u Birmingham Womens Hospital Healthcare NHS Trust, W Midlands Reg Genet Serv, Birmingham, W Midlands, England4 aut
700	1	a Cook, J.4 aut
700	1	a Paterson, J.u Addenbrookes Hospital, Department Clin Genet, E Anglian Reg Genet Serv, Cambridge, England4 aut
700	1	a Hodgson, S.u University London, Department Clin Genet, St Georges Hospital, London, England4 aut
700	1	a Morrison, P. J.u Belfast City Hospital, Northern Ireland Reg Genet Centre, Belfast BT9 7AD, Antrim, North Ireland4 aut
700	1	a Porteous, M. E.u Western Gen Hospital, SE Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland4 aut
700	1	a Walker, L.u Churchill Hospital, Oxford Reg Genet Serv, Oxford OX3 7LJ, England4 aut
700	1	a Kennedy, M. J.u St James Hospital, Canc Genet Program, Hope Directorate, Dublin, Ireland4 aut
700	1	a Dorkins, H.u Kennedy Galton Centre, NW Thames Reg Genet Serv, Harrow, Middx, England4 aut
700	1	a Peock, S.u University Cambridge, Centre Canc Genet Epidemiol, Department Publ Hlth and Primary Care, Cambridge, England4 aut
700	1	a Godwin, A. K.u Fox Chase Canc Centre, Department Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA,Tech University Dresden, Department Obstet and Gynaecol, University Hospital Carl Gustav Carus, Dresden, Germany,University Helsinki, Cent Hospital, Department Clin Genet, Helsinki, Finland4 aut
700	1	a Stoppa-Lyonnet, D.u University Paris 05, INSERM, U509, Serv Genet Oncol,Institute Curie, Paris, France4 aut
700	1	a De Pauw, A.u University Paris 05, INSERM, U509, Serv Genet Oncol,Institute Curie, Paris, France4 aut
700	1	a Mazoyer, S.u University Lyon 1, CNRS, Centre Leon Berard, Equipe Labellisee LIGUE 2008,UMR5201, F-69365 Lyon, France4 aut
700	1	a Bonadona, V.u University Lyon 1, CNRS, UMR5558, F-69365 Lyon, France4 aut
700	1	a Lasset, C.u University Lyon 1, CNRS, UMR5558, F-69365 Lyon, France4 aut
700	1	a Dreyfus, H.u CHU Grenoble, Department Genet, F-38043 Grenoble, France4 aut
700	1	a Leroux, D.u CHU Grenoble, Department Genet, F-38043 Grenoble, France4 aut
700	1	a Hardouin, A.u Centre Francois Baclesse, F-14021 Caen, France4 aut
700	1	a Berthet, P.u Centre Francois Baclesse, F-14021 Caen, France4 aut
700	1	a Faivre, L.u Centre Hospital University Dijon, Centre Genet, Dijon, France4 aut
700	1	a Loustalot, C.u Centre Lutte Canc Georges Francois Leclerc, Dijon, France4 aut
700	1	a Noguchi, T.u INSERM, Institute Paoli Calmettes, UMR599, Department Oncol Genet, F-13258 Marseille, France4 aut
700	1	a Sobol, H.u INSERM, Institute Paoli Calmettes, UMR599, Department Oncol Genet, F-13258 Marseille, France4 aut
700	1	a Rouleau, E.u Centre Rene Huguenin, INSERM, U735, St Cloud, France4 aut
700	1	a Nogues, C.4 aut
700	1	a Frénay, M.u Centre Antoine Lacassagne, F-06054 Nice, France4 aut
700	1	a Vénat-Bouvet, L.u Centre Hospital University Limoges, Department Oncol, Limoges, France4 aut
700	1	a Hopper, J. L.u University Copenhagen, Rigshosp, Department Clin Biochem, DK-2100 Copenhagen, Denmark4 aut
700	1	a Daly, M. B.u IEO, Div Canc Prevent and Genet, Milan, Italy,Fox Chase Canc Centre, Department Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA4 aut
700	1	a Terry, M. B.u Columbia University, New York, NY USA4 aut
700	1	a John, E. M.4 aut
700	1	a Buys, S. S.u University Utah, Hlth Science Centre, Huntsman Canc Institute, Salt Lake City, UT USA4 aut
700	1	a Yassin, Y.u Cedars Sinai Med Centre, Womens Canc Research Institute, Samuel Oschin Comprehens Canc Institute, Los Angeles, CA 90048 USA4 aut
700	1	a Miron, A.4 aut
700	1	a Goldgar, D.4 aut
700	1	a Singer, C. F.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut
700	1	a Dressler, A. C.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut
700	1	a Gschwantler-Kaulich, D.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut
700	1	a Pfeiler, G.u Med University Vienna, Department Obstet and Gynecol, Vienna, Austria4 aut
700	1	a Hansen, T. V. O.4 aut
700	1	a Jnson, L.4 aut
700	1	a Bergman, Annikau Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik,Institute of Biomedicine, Department of Medical and Clinical Genetics4 aut0 (Swepub:gu)xbannj
700	1	a Kirchhoff, T.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut
700	1	a Offit, K.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut
700	1	a Devlin, V.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut
700	1	a Dutra-Clarke, A.u Mem Sloan Kettering Canc Centre, Department Med, Clin Genet Serv, New York, NY 10021 USA4 aut
700	1	a Piedmonte, M.u Roswell Pk Canc Institute, GOG Stat and Data Centre, Buffalo, NY 14263 USA4 aut
700	1	a Rodriguez, G. C.u NorthShore University Hlth Syst, Evanston NW Healthcare, Evanston, IL USA4 aut
700	1	a Wakeley, K.u Tufts University, New England Med Centre, Boston, MA 02111 USA4 aut
700	1	a Boggess, J. F.u University N Carolina, Chapel Hill, NC USA4 aut
700	1	a Basil, J.u St Elizabeth Hospital, Edgewood, KY USA4 aut
700	1	a Schwartz, P. E.u Yale University, Sch Med, New Haven, CT USA4 aut
700	1	a Blank, S. V.u NYU, Sch Med, New York, NY USA4 aut
700	1	a Toland, A. E.u Ohio State University, Centre Comprehens Canc, Department Internal Med and Mol Virol, Div Human Canc Genet, Columbus, OH 43210 USA4 aut
700	1	a Montagna, M.4 aut
700	1	a Casella, C.4 aut
700	1	a Imyanitov, E.u NN Petrov Institute Oncol, St Petersburg, Russia4 aut
700	1	a Tihomirova, L.u Latvian Biomed Research and Study Centre, Riga, Latvia4 aut
700	1	a Blanco, I.u Catalan Institute Oncol IDIBELL, Hereditary Canc Program, Barcelona, Spain4 aut
700	1	a Lazaro, C.u Catalan Institute Oncol IDIBELL, Hereditary Canc Program, Barcelona, Spain4 aut
700	1	a Ramus, S. J.u University London Imperial Coll Science Technology and Med, Gynaecol Oncol Unit, UCL EGA Institute Womens Hlth, London, England,Centre Hospital University Quebec, Canada Research Chair Oncogenet, Canc Genom Lab, Quebec City, PQ, Canada4 aut
700	1	a Sucheston, L.4 aut
700	1	a Karlan, B. Y.4 aut
700	1	a Gross, J.u Cedars Sinai Med Centre, Womens Canc Research Institute, Samuel Oschin Comprehens Canc Institute, Los Angeles, CA 90048 USA4 aut
700	1	a Schmutzler, R.u University Cologne, Centre Familial Breast and Ovarian Canc, Department Obstet and Gynaecol, Cologne, Germany4 aut
700	1	a Wappenschmidt, B.u University Cologne, Centre Familial Breast and Ovarian Canc, Department Obstet and Gynaecol, Cologne, Germany4 aut
700	1	a Engel, C.u University Leipzig, Institute Med Informat Stat and Epidemiol, Leipzig, Germany4 aut
700	1	a Meindl, A.4 aut
700	1	a Lochmann, M.u Tech University Munich, Klinikum Rechts Isar, Department Obstet and Gynaecol, Div Tumor Genet, D-8000 Munich, Germany4 aut
700	1	a Arnold, N.u University Kiel, Department Obstet and Gynaecol, University Hospital Schleswig Holstein, Kiel, Germany4 aut
700	1	a Heidemann, S.u University Kiel, Institute Human Genet, University Hospital Schleswig Holstein, Kiel, Germany4 aut
700	1	a Varon-Mateeva, R.u Campus Virchow Klinikum, Charite Berlin, Institute Human Genet, Berlin, Germany4 aut
700	1	a Niederacher, D.u University Dusseldorf, Department Obstet and Gynaecol, Div Mol Genet, University Hospital Dusseldorf, Dusseldorf, Germany4 aut
700	1	a Sutter, C.u University Heidelberg, Institute Human Genet, Div Mol Diagnost, Heidelberg, Germany4 aut
700	1	a Deissler, H.u University Hospital Ulm, Department Obstet and Gynaecol, Ulm, Germany4 aut
700	1	a Gadzicki, D.4 aut
700	1	a Preisler-Adams, S.u University Hospital Muenster, Institute Human Genet, Munster, Germany4 aut
700	1	a Kast, K.4 aut
700	1	a Schönbuchner, I.u University Wurzburg, Institute Human Genet, Div Med Genet, Wurzburg, Germany4 aut
700	1	a Caldes, T.u Hospital Clin San Carlos, Mol Oncol Lab, Madrid, Spain4 aut
700	1	a De La Hoya, M.u Hospital Clin San Carlos, Mol Oncol Lab, Madrid, Spain4 aut
700	1	a Aittomäki, K.4 aut
700	1	a Nevanlinna, H.u University Helsinki, Cent Hospital, Department Obstet and Gynecol, FIN-00290 Helsinki, Finland4 aut
700	1	a Simard, J.4 aut
700	1	a Spurdle, A. B.4 aut
700	1	a Holland, H.4 aut
700	1	a Chen, X.u Queensland Institute Med Research, Brisbane, Qld, Australia4 aut
700	1	a Platte, R.u Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom4 aut
700	1	a Chenevix-Trench, G.u Queensland Institute of Medical Research, Brisbane, Australia4 aut
700	1	a Easton, D. F.4 aut
700	1	a Bergman, Annikau Sahlgrenska University Hospital, Gothenburg, Sweden4 ctb0 (Swepub:hj)berann
700	1	a Einbeigi, Zakaria,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xeinza
700	1	a Karlsson, Per,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xkperd
700	1	a DallOlio, Valentinau Cogentech, Consortium Genom Technology, Milan, Italy4 aut
710	2	a Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdomb University Turin, Department Genet Biol and Biochem, Turin, Italy4 org
710	2	a Ontario Cancer Genetics Network
773	0	t Cancer Researchd : American Association for Cancer Researchg 70:23, s. 9742-9754q 70:23<9742-9754x 0008-5472x 1538-7445
856	4	u http://dx.doi.org/10.1158/0008-5472.CAN-10-1907y FULLTEXT
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-39678
856	4 8	u https://doi.org/10.1158/0008-5472.CAN-10-1907
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-39274
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-140191
856	4 8	u https://lup.lub.lu.se/record/1751787
856	4 8	u https://gup.ub.gu.se/publication/135360
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:121669047
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63965

Hitta via bibliotek

Cancer Research (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Antoniou, A. C.; Beesley, J.; McGuffog, L.; Sinilnikova, O. ...; Healey, S.; Neuhausen, S. L.; visa fler...; Ding, Y. C.; Rebbeck, T. R.; Weitzel, J. N.; Lynch, H. T.; Isaacs, C.; Ganz, P. A.; Tomlinson, G.; Olopade, O. I.; Couch, F. J.; Wang, X.; Nordling, Margar ...; Pankratz, V. S.; Radice, P.; Manoukian, S.; Peissel, B.; Zaffaroni, D.; Stenmark-Askmalm ...; Viel, A.; Allavena, A.; Dall'Olio, V.; Peterlongo, P.; Szabo, C. I.; Zikan, M.; Claes, K.; Poppe, B.; Foretova, L.; Mai, P. L.; Greene, M. H.; Rennert, G.; Lejbkowicz, F.; Glendon, G.; Ozcelik, H.; Andrulis, I. L.; Thomassen, M.; Gerdes, A. -M; Sunde, L.; Cruger, D.; Jensen, U. B.; Caligo, M.; Friedman, E.; Kaufman, B.; Laitman, Y.; Milgrom, R.; Dubrovsky, M.; Cohen, S.; Borg, A.; Jernström, Helen ...; Lindblom, A.; Rantala, J.; Stenmark-Askmalm ...; Melin, Beatrice; Nathanson, K.; Domchek, S.; Jakubowska, A.; Lubinski, J.; Huzarski, T.; Osorio, A.; Lasa, A.; Durán, M.; Tejada, M. -I; Godino, J.; Benitez, J.; Hamann, U.; Kriege, M.; Hoogerbrugge, N.; Van Der Luijt, R ...; Van Asperen, C. ...; Devilee, P.; Meijers-Heijboer ...; Blok, M. J.; Aalfs, C. M.; Hogervorst, F.; Rookus, M.; Cook, M.; Oliver, C.; Frost, D.; Conroy, D.; Evans, D. G.; Lalloo, F.; Pichert, G.; Davidson, R.; Cole, T.; Cook, J.; Paterson, J.; Hodgson, S.; Morrison, P. J.; Porteous, M. E.; Walker, L.; Kennedy, M. J.; Dorkins, H.; Peock, S.; Godwin, A. K.; Stoppa-Lyonnet, ...; De Pauw, A.; Mazoyer, S.; Bonadona, V.; Lasset, C.; Dreyfus, H.; Leroux, D.; Hardouin, A.; Berthet, P.; Faivre, L.; Loustalot, C.; Noguchi, T.; Sobol, H.; Rouleau, E.; Nogues, C.; Frénay, M.; Vénat-Bouvet, L.; Hopper, J. L.; Daly, M. B.; Terry, M. B.; John, E. M.; Buys, S. S.; Yassin, Y.; Miron, A.; Goldgar, D.; Singer, C. F.; Dressler, A. C.; Gschwantler-Kaul ...; Pfeiler, G.; Hansen, T. V. O.; Jnson, L.; Bergman, Annika; Kirchhoff, T.; Offit, K.; Devlin, V.; Dutra-Clarke, A.; Piedmonte, M.; Rodriguez, G. C.; Wakeley, K.; Boggess, J. F.; Basil, J.; Schwartz, P. E.; Blank, S. V.; Toland, A. E.; Montagna, M.; Casella, C.; Imyanitov, E.; Tihomirova, L.; Blanco, I.; Lazaro, C.; Ramus, S. J.; Sucheston, L.; Karlan, B. Y.; Gross, J.; Schmutzler, R.; Wappenschmidt, B ...; Engel, C.; Meindl, A.; Lochmann, M.; Arnold, N.; Heidemann, S.; Varon-Mateeva, R ...; Niederacher, D.; Sutter, C.; Deissler, H.; Gadzicki, D.; Preisler-Adams, ...; Kast, K.; Schönbuchner, I.; Caldes, T.; De La Hoya, M.; Aittomäki, K.; Nevanlinna, H.; Simard, J.; Spurdle, A. B.; Holland, H.; Chen, X.; Platte, R.; Chenevix-Trench, ...; Easton, D. F.; Einbeigi, Zakari ...; Karlsson, Per, 1 ...; DallOlio, Valent ...; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Cancer och onkol ...

Artiklar i publikationen: Cancer Research

Av lärosätet: Jönköping University; Umeå universitet; Uppsala universitet; Lunds universitet; Göteborgs universitet; Karolinska Institutet; visa fler...; Linköpings universitet; visa färre...

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se